Reuters logo
BRIEF-Gabather receives patent in India for l1001c triazoloderivat
October 3, 2017 / 6:59 AM / 2 months ago

BRIEF-Gabather receives patent in India for l1001c triazoloderivat

Oct 3 (Reuters) - GABATHER AB

* RECEIVED PATENT FROM INDIAN PATENT OFFICE FOR COMPANY‘S PATENT FAMILY, L1001C TRIAZOLODERIVAT, IN WHICH SUBSTANCE GT-002 IS DESCRIBED. PATENT IS VALID UNTIL 2029 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below